Patents by Inventor Weiping Jiang

Weiping Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108566
    Abstract: A composition containing recombinant collagen with repairing and soothing effects, eye cream containing the composition and preparation method thereof are provided. The composition contains the following raw materials in parts by weight: 1 to 10 parts of recombinant collagen, 1 to 10 parts of sodium hyaluronate, 1 to 5 parts of bifida ferment lysate, 1 to 15 parts of glucosylglycerol, 1 to 10 parts of bisabolol, 1 to 15 parts eight-treasure essence stock solution, and 1 to 15 parts of pink red plum rechecking essence. The composition features with good skin permeability, contributing to its significant effects on repairing skin barriers and relieving skin inflammation, as well as its advantages of low irritation and high safety. Thus, the composition is suitable for people with damaged eye skin and has good market application prospects.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 4, 2024
    Inventors: Daonian ZHOU, Chang TAN, Jinlong SUN, Mingjia LI, Ge CHEN, Weiping ZHANG, Heng ZHANG, Lei JIANG, Li ZHOU, Jincheng QI
  • Publication number: 20240100066
    Abstract: Provided is an oral Pt(IV) anticancer prodrug containing a 3-bromopyruvate as an axial ligand, with a molecular formula of cis,trans,cis-[Pt(1R,2R-diaminocyclohexane)(OH)(3-bromopyruvate)(C2O4)]. It is a prodrug of oxaliplatin and 3-bromopyruvic acid is a small molecular glycolysis inhibitor. The prodrug is able to simultaneously act on DNA replication and glycolytic pathways of cancer cells, giving full play to the advantage of double-acting targets. The oral Pt(IV) anticancer prodrug is synthesized by using oxaliplatin as a starting material, performing axial oxidation with H2O2 and neutralizing the oxidized product with 3-bromopyruvic acid.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 28, 2024
    Inventors: Weiping Liu, Chen Qing, Anli Gao, Peng Zhou, Jing Jiang, Hongyu Zhou, Juan Yu, Lingling Zhang
  • Publication number: 20240092814
    Abstract: Provided are a water-soluble Pd(II) complex, a synthesis method thereof and use thereof as a catalytic precursor. The complex has a chemical name, ammonium dinitrooxalato palladium (II), and a molecular formula of (NH4)2[Pd(NO2)2(C2O4)]·nH2O (n is the number of crystal water). The Pd(II) complex is synthesized by using PdCl2 or [Pd(NH3)2Cl2] as a starting material which is firstly converted into [Pd(NH3)4]Cl2 in ammonium hydroxide, followed by a chemical reaction between [Pd(NH3)4]Cl2 and excessive NaNO2 to produce trans-[Pd(NH3)2(NO2)2] via ligand substitution mechanism, and finally dissolving trans-[Pd(NH3)2(NO2)2] in an aqueous solution of oxalic acid leads to the formation of the target product (NH4)2[Pd(NO2)2(C2O4)]·2H2O. The complex does not contain chlorine and other elements that are harmful to a catalyst, is readily soluble in water and has a low thermal decomposition temperature.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 21, 2024
    Inventors: Weiping Liu, Juan Yu, Li Chen, Anli Gao, Yunsheng Dai, Feng Liu, Jing Jiang, Jiyang Xie, Hao Zhou, Qiaowen Chang, Caixian Yan
  • Publication number: 20210093640
    Abstract: The present invention discloses a group of polycyclic carbamoylpyridone derivatives, pharmaceutical compositions, and a use thereof. The structure of the polycyclic carbamoylpyridone derivatives of the present invention is represented by formula (VII). The polycyclic carbamoylpyridone derivative of the present invention functions as an inhibitor of influenza 5?cap-like structure (CAP)-dependent endonuclease activity and can be used to treat a cold caused by the influenza virus. The present invention also discloses a pharmaceutical composition to inhibit proliferation of the influenza virus.
    Type: Application
    Filed: April 11, 2019
    Publication date: April 1, 2021
    Inventors: Xiaoyun ZHU, Weiping JIANG
  • Patent number: 9670680
    Abstract: The present invention relates to the sector of building materials, and more specifically, to a floor connector and a floor with the floor connector. The floor connector includes a first connecting part and a second connecting part used to connect floors, and a supporting part arranged between the bottom surface of the first connecting part and the upper surface of the second connecting part for the purpose of supporting the first connecting part and the second connecting part. The floor includes a main body, a floor pedestal arranged under the main body, and a floor connector used to connect the main body and the floor pedestal. In this solution, the floor can be arranged without a keel, thereby significantly reducing the labor intensity during floor installation. Consisting of three parts, the floor features lightweight and simplification of installation procedure.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: June 6, 2017
    Inventor: Weiping Jiang
  • Publication number: 20170058535
    Abstract: The present invention relates to the sector of building materials, and more specifically, to a floor connector and a floor with the floor connector. The floor connector includes a first connecting part and a second connecting part used to connect floors, and a supporting part arranged between the bottom surface of the first connecting part and the upper surface of the second connecting part for the purpose of supporting the first connecting part and the second connecting part. The floor includes a main body, a floor pedestal arranged under the main body, and a floor connector used to connect the main body and the floor pedestal. In this solution, the floor can be arranged without a keel, thereby significantly reducing the labor intensity during floor installation. Consisting of three parts, the floor features lightweight and simplification of installation procedure.
    Type: Application
    Filed: June 17, 2016
    Publication date: March 2, 2017
    Inventor: Weiping Jiang
  • Patent number: 7601835
    Abstract: Purine derivatives of formula I, substituted at the 9-position, are prepared from a chloro substituted purine starting material, first making an alkyl substitution at the 9-position, then forming the desired esterified side chain, reducing this and hydrogenating the resultant diol prior to addition of alkyl carbonyl groups.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: October 13, 2009
    Assignee: Arrow International Limited
    Inventors: Liang He, Weiping Jiang
  • Publication number: 20060264629
    Abstract: Purine derivatives, substituted at the 9-position, are prepared from a chloro substituted purine starting material, first making an alkyl substitution at the 9-position, then forming the desired esterified side chain, reducing this and hydrogenating the resultant diol prior to addition of alkyl carbonyl groups.
    Type: Application
    Filed: November 10, 2005
    Publication date: November 23, 2006
    Applicants: Arrow International Limited, Chongqing Shenghuaxi Pharmaceutical Co. Ltd.
    Inventors: Liang He, Weiping Jiang